Alyeska Investment Group, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 90 filers reported holding HERON THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$21,398,000
-10.4%
775,299
-41.3%
0.18%
-6.8%
Q4 2017$23,891,000
+96.0%
1,319,945
+74.9%
0.19%
+108.8%
Q3 2017$12,188,000
+27.6%
754,657
+9.5%
0.09%
+13.8%
Q2 2017$9,548,000
-20.1%
689,397
-13.4%
0.08%
-17.5%
Q1 2017$11,945,000
+74.2%
796,331
+52.1%
0.10%
+70.2%
Q4 2016$6,859,000
+102.7%
523,597
+166.7%
0.06%
+83.9%
Q3 2016$3,383,000
+48.8%
196,342
+25.6%
0.03%
-3.1%
Q1 2015$2,274,000
+31.7%
156,268
-8.9%
0.03%
+10.3%
Q4 2014$1,726,000
+64.9%
171,554
+36.5%
0.03%
+31.8%
Q3 2014$1,047,000125,6690.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders